午夜一级毛片-手机看片99-动漫人物桶机免费动漫app-日日摸日日碰夜夜97|www.zyjlr.com

TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
Chengdu: drug companies these 15 behaviors, report to have a prize of up to 300,000!
 
Author:中國銘鉉 企劃部  Release Time:2017-8-7 14:26:36  Number Browse:619
 
The medical website on August 7, the ticket, hangs up carefully, may be reported at any time! 
 
August 4 in the morning, the food and drug administration of chengdu on its official issued a message - the general office of the people's government of chengdu forward feed, food and drug administration bureau about the incentives for reporting behavior of chengdu food and drug law (trial) notice - including walking ticket, and sales call JiaLie high-risk behavior in the field of medicinal herbs and other drugs may be reported at any time. 
 
It is reported that chengdu has set up a special reward money, food and drug offence reporting needed to reward fund into the fiscal budgets at various levels, that is to say, incentive bonus all fiscal spending by the government, which is why the root cause of the financial department to participate in the papers. 
 
▍ 15 kinds of circumstances may be reported 
 
According to the "way", chengdu reported one of the following information related to the food and drug violations or, drug safety management department shall reward whistleblowers, which involved in the field of pharmaceuticals article 15: 
 
1. Production, marketing, use of counterfeit drugs and substandard drugs. 
 
2. Medical preparations are made without permission. 
 
3. Drug production and distribution shall not be carried out according to the production process or processing specifications approved by the state pharmaceutical standards, the state council or the provincial pharmaceutical supervisory and administrative departments. 
 
4. Falsification or alteration of drug production (preparation) records. 
 
5. Entrusted or entrusted to produce drugs without approval. 
 
6. Major drug quality accidents in pharmaceutical production enterprises have not been reported in accordance with the regulations. 
 
7. Fabricating, using false qualification to sell or defraud the preparation of special medicines such as ephedrine. 
 
8. Sales of ephedrine compound preparations or antibiotics, in violation of special drugs or drug classification management regulations. 
 
9. In violation of the provisions of the management of direct contact drug packaging materials, the production and sale of pharmaceutical packaging materials, and the sale or import of unqualified pharmaceutical materials, and the use of unqualified pharmaceutical packaging materials. 
 
10. Drug manufacturers have found that there are safety concerns and do not actively recall drugs. 
 
11. Domestic sales of Chinese medicinal materials are sold in domestic and inferior medicines. 
 
12. Pharmaceutical retail enterprises and medical institutions have purchased Chinese medicinal materials from the professional market of medicinal materials. 
 
13. It is known or should be aware that drugs come from illegal channels and are still sold or used. 
 
14. Taking "walking ticket" and "hanging up" etc. 
 
15. Refrigerated or refrigerated drugs are required to escape the "cold chain" during their storage and transportation. 
 
▍ highest awards 300000 
 
According to the report, the report is divided into three grades. Where one of the first-level reporting rewards is awarded, the award shall be 8% to 12% according to the value of the case, and the minimum award shall be 1000 yuan. 
 
The reward of the second-level report shall be awarded according to the value of the case value of 4% to 8%, and the minimum reward shall be 600 yuan. 
 
Those who are awarded in the third grade shall be awarded 2% to 4% of the value of the case, and the minimum reward shall be 200 yuan. 
 
If a reward is awarded to a reward for reward, the above criteria may be awarded, but in principle no more than one times the original reward standard. 
 
At the same time, the method stipulates that the reward for each case should not exceed 300,000 yuan in principle. 
 
▍ introspection, demining 
 
As early as 2013, when the CFDA, ministry of finance will have jointly issued on the incentives for report issued by the food and drug illegal conduct of the notice, also puts forward the principle, the single case is highest reward 300000 yuan. 
 
But the CFDA's approach is less refined, and there is no single case of tip-offs to the drug, and the chengdu version is more detailed. 
 
The drug companies can self-check, besides the ignorance of the criminals, there is nowhere to step on the land mines? 

 
Previous article:Health reform innovation model sanming city targeted medical equipment finance lease
Next article:There are too many tertiary hospitals, and Chinese hospitals will be reshuffled
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粵公網安備 44011202000029號